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Abstract 
Constructing smart nano-systems for intracellular delivery of functional proteins has 
been endeavored for diverse biomedical applications, but suffered daunting 
challenges. Herein silica nanospheres entrapped with photoluminescent CaF2:Tm,Yb 
nanocrystals were synthesized and decorated with amino molecules for protein 
delivery. Amino-modified nanospheres presented high protein loading capacity and 
sustained release phenomenon. The photoluminescence of particles highly 
corresponded to protein release progress. The preliminary in-vitro study confirmed 
markedly enhanced cell up-taking efficiency of protein molecules with the 
nanocomposite developed. 
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1. Introduction 
Intracellular delivery with certain proteins plays a fundamental role in diverse 
biomedical applications, from restoring the function of interest, producing highly 
specific molecules in situ, to regulating gene expression without minimal genomic 
alteration [1,2]. The main mechanism is to deliver protein complex (e.g., 
multicomponent protein assemblies or post-translationally modified proteins) into 
cells in a rational manner as these proteins require exquisite cellular machinery for 
production, which may not be present or fully functional in the host cell [3,4]. 
However, in general physiological environment, most of proteins intend to undergo 
degradation by proteolytic enzymes or, in the case of the higher-molecular-weight 
proteins, may be recognized by neutralizing antibodies [5,6]. The fragility of most 
therapeutic proteins and impermeability of cell membrane limit effective 
intracellular delivery of protein molecules [7]. In general, two criteria for enabling 
expected protein therapy shall be met: transportation to cell cytoplasm and 
retention of biological activity at the targeted site of action [8]. An efficient protocol 
for intracellular delivery of native, functional proteins, in an active conformation, is of 
crucial significance, but suffered daunting challenges. 
In the past decade, nanocarrier-based approaches, such as mesoporous silica 
nanoparticles (MSNs), for intracellular protein delivery have attracted considerable 
interest worldwide [9, 10]. Slowing et al. reported successful intracellular delivery of 
membrane-impermeable protein cytochrome c (Cyto C) using MSNs [11]. Bale et al. 
demonstrated that silica nanoparticles enabled effective intracellular delivery of 
Ribonuclease A (RNase A) [4]. Conventional silica nanoparticles, where only external 
surface can be utilized for protein attachment due to the large dimensions of 
macromolecules [12], may induce low protein loading capacity and burst release. 
Meanwhile, silica hollow spheres, synthesized with current hard templating and 
microemulsion approaches, may present large pores (>10 nm) [13], but its particle 
size in the micrometer range hinders the up-taking behavior of cells. Therefore, the 
investigation of silica nanospheres endowed with low dimensions as well as new 
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protocols for protein immobilization is being endeavored. 
In addition to transportation strategies, the controlled and monitored release of 
proteins from the nanocarriers is equally vital for avoiding unexpected extracellular 
burst release [14]. A possible approach for tracking protein release in an in-situ 
manner may draw a lesson from a photo-imaging strategy. Silica based nanomaterials 
functionalized with fluorescence compounds have been developed for biological 
imaging purposes [15-17]. Under the excitation of 980 nm NIR laser, Tm/Yb co-doped 
fluorides nanocrystals exhibit forceful upconverted luminescence, making them ideal 
for cell imaging applications [18]. However, for current UC photoluminescent silica 
materials which generally consist of luminescent core and silica shell, the synthesis 
methodologies usually involves cumbersome procedures, and the thin silica shell 
limits its effective storage of functional molecules [19].
 
In this work, fine photoluminescent CaF2:Yb
3+
,Tm
3+
 nanocrystals were 
embedded mesoporous silica nanoparticles (CaF2:Yb,Tm@MSNs), and the 
up-conversion nanoparticles (UCNPs) synthesized were modified with amino groups 
at the surface. Bovine serum albumin (BSA) was used as a macromolecular protein 
model. The protein loading capacity, release kinetics and corresponding 
photoluminescent phenomena of UCNPs were studied (Scheme 1). More importantly, 
the superior efficacy of intracellular protein transport by this new delivery platform 
was demonstrated. 
 
2. Experimental section 
2.1 Synthesis of luminescent silica nanospheres 
In a typical procedure, 0.2 g cetyltrimethylammonium bromide (CTAB, ≥99%, 
Sigma–Aldrich Inc.), 25 mL deionized water, 5 mL ethanol, 50 μL of triethanolamine 
(TEA, Sinopharm Chemical Reagent) were mixed and stirred at 60 
o
C for 30 minutes. 
Subsequently, 2 mL tetraethylorthosilicate (TEOS, Sigma–Aldrich Inc., USA) was 
added into the solution under stirring for 2 h. When white participate appeared, the 
solution was cooled down to the ambient temperature, and the precipitate was 
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collected by centrifugation. After being air-dried at 80 
o
C, the particles were further 
calcined at 550 oC for 5 h to obtain MSNs. To incorporate CaF2:Tm,Yb nanocrystals 
within MSNs, a mixed ionic solution of Ca2+, Tm3+ and Yb3+ was prepared by dissolving 
their corresponding acetates in deionized water, and then added with trifluoroacetic 
acid (TFA, 99%，Sigma–Aldrich Inc.) under stirring overnight at 40 oC. Subsequently, 
400 mg of the as-synthesized MSNs was added into 20 mL of the as-prepared solution 
and immersed for 24 h under stirring at 40 
o
C. The particles were then collected by 
centrifuging and dried at 80 oC for 3 h and sintered at 600 oC for 3 h. The 
functionalization of luminescent nanoparticles with amino groups was then carried 
out following the modified existing protocols. Briefly, 100 mg of as-prepared particles 
was dispersed in 100 ml ethanol under sonication for 30 min, and 1.5 mL 
3-aminopropyltriethoxysilane (APTES, Sinopharm Chemical ReagentCo., Ltd.) was 
added dropwise. After stirring for 24 h at 40 
o
C, the samples were collected by 
centrifugation and washed with ethanol to remove the excessive APTES molecules. 
 
2.2 In vitro cytotoxicity assay 
Cytotoxicity of luminescent nanosphere was assessed using fibroblast by Cell 
Counting Kit-8 method (CCK-8; Dojindo, Kamimashiki-gun Kumamoto, Japan). Briefly, 
cells were seeded into 96-well plate and incubated with particles for 24 hours and 48 
hours. The particles concentration was ranged from 0 to-200 μg mL
-1
. At each time 
point, the medium was refreshed, and 10 μL of CCK-8 solution was added and 
incubated at 37 oC for 4 hours. The cytotoxicity of nanospheres was examined by 
measuring the absorbance at 450 nm using a microplate reader (BIO-TEK Instruments, 
Minneapolis, USA). 
 
2.3 Loading and release of BSA protein 
Bovine serum albumin (BSA, 99%, Sigma–Aldrich) was dissolved in 20 mL 
phosphate buffer solution (PBS) at pH 7.4 to produce a stock solution with a 
concentration of 2 mg mL−1. Unmodified and amino-modified nanoparticles (50 mg) 
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were added into BSA solution at ambient temperature. The mixture was 
subsequently stirred for 24 h at room temperature to achieve the equilibrium state. 
The BSA-loaded nanoparticles were then collected by centrifugation and washed with 
PBS to remove the excess BSA protein. The in vitro BSA protein releasing test was 
performed by immersing the BSA loaded nanoparticles in 20 mL of PBS (pH=7.4) at 37 
± 0.1 
o
C. At predetermined time intervals, a 10 mL buffer solution was collected and 
immediately replaced with an equal volume of fresh PBS. The amount of BSA 
released in PBS solution was measured using a UV−vis spectrophotometer (TU-1810, 
China) at an absorbance of characteristic wavelength (λ=278–280 nm). Three 
measurements were performed for each sample. 
 
2.4 Intracellular monitoring of BSA release. 
Confocal microscopy luminescence imaging was carried out using a modified 
OLYMPUS FV1000 equipped a 980 nm laser diode. HepG2 cells (1×10
4
/mL) were 
seeded onto a glass coverslips in 24-well plates and incubated for 24 h prior to cell 
culture. Subsequently, the original cell culture media was replaced with medium 
containing amino-modified UCNPs and BSA loaded amino-modified UCNPs (100 
μg/mL). Subsequently, confocal microscopy luminescence imaging was carried out at 
scheduled time intervals. Upconversion luminescence of amino-modified UCNPs was 
detected under excitation at 980 nm laser. 
 
2.5 In vitro cellular uptaking performance of BSA protein 
HepG2 cells were seeded in 6- well plates in 2.0 ml of complete DMEM culture 
media (10 % FBS) at a density of 6×10
5
 cells per well and incubated for 24 h under 
standard incubation conditions. Then, the original cell culture media were replaced 
with FITC-labeled BSA loaded nanoparticles (100 μg/mL) in 2.0 mL of complete 
DMEM culture media (10 % FBS) for each well and the cells were further incubated 
for 24 and 48 h. After removing the medium, the cells were washed with PBS for 3 
times and fluorescence microscope (Nikon ECLIPSE Ti) was performed using to get 
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the green fluorescence.  
Flow cytometry analysis was performed to evaluate the BSA protein cellular 
uptake efficiency quantitatively. HepG2 cells were seeded in 6-well plates at a density 
of 6×10
5
 cells per well and incubated for 24 h. Then, the original cell culture media 
was replaced with FITC-labeled BSA loaded nanoparticles (100 μg/mL) in 2.0 mL of 
complete DMEM culture media (10 % FBS) for each well. After cultured for 24 and 48 
h, the media was removed. Then, the cells were trypsinized, washed with PBS, 
centrifuged, and resuspended in PBS buffer. Flow cytometry (NovoCyte 3130 (DEMO)) 
was carried out to measured the cell up-taking efficiency. Cells without FITC-labeled 
BSA loaded nanoparticles incubation were used as a control. 
 
2.6 Characterization 
The morphology of particles was characterized by field-emission scanning 
electron microscopy (FESEM, Hitachi SU-70, Japan) operated at 3 kV and 
high-resolution transmission electron microscopy (HRTEM, Tecnai F20, FEI, USA) 
operated at 200 kV. The phase and crystal structure were characterized by an X-ray 
diffraction instrument (XRD, X’Pert PRO MPD, The Netherlands) operating at 40 mA 
and 40 kV using Cu Kα radiation. The scan range was set at 20° < 2θ < 60° with a step 
size of 0.167°. The FTIR spectra were recorded on a PerkinElmer 580B infrared 
spectrophotometer on KBr pellets (Tensor 27, Bruker, Germany) in the frequency 
range of 4000–400 cm−1 with a resolution of 4 cm−1. Thermogravimetry/differential 
scanning calorimetry (TG-DSC, DSCQ1000, AT, USA) was used to measure the quantity 
of BSA loaded onto the nanoparticles in air with a heating rate of 10 oC/min from 25 
to 700 
o
C. The upconversion photoluminescence spectra were recorded at room 
temperature under excitation by 980 nm laser from a fluorescence 
spectrophotometer (PL, FLSP920, Edinburgh). To minimize experimental accidental 
error, the sample positions and the spectra collection were maintained in identical 
conditions. 
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3. Results and Discussion 
3.1. Characteristics of CaF2:Tm,Yb@mSiO2 up-conversion nanoparticles 
(UCNPs) 
The approach for synthesizing CaF2:Tm,Yb@mSiO2 UCNPs involved the 
preparation of mesoporous SiO2 nanoparticles as templates, followed by the 
formation of CaF2:Tm,Yb nanocrystals within its mesopores. TEM images of the 
as-prepared MSNs (Fig. S1) indicate the typical porous structure. Further, N2 
adsorption/desorption examination was performed to quantify the specific surface 
area and pore-size distribution. Apparent mesoporous characteristics of plateau 
regions were observed for the MSNs (Fig. S2). The specific surface area and pore 
volume of particles are ~729.3 m
2
/g and ~0.725 cm
3
/g, respectively. The average 
pore size of MSNs is ~5.04 nm (Table S1). The UCNPs synthesized exhibited uniform 
morphology and narrow size distribution with an average diameter of ～65 nm (Fig 
1a). The examination using energy dispersive spectroscopy (EDS) confirmed the 
homogeneous distribution of Si, O, Ca, F, Yb and Tm elements within MSNs matrix 
(Fig S3). The microstructure of UCNPs was examined using TEM (Fig 1b-c). It was 
found that a large number of ‘dark spots‘ (with dimensions up to 3~5nm) distribute 
homogeneously within the matrix of MSNs. In addition, the SAED pattern shows 
distinct diffraction rings, implying the crystalline nature of the spots formed. The 
lattice fringes of crystalline phase are clear in the HRTEM image, and the distance 
between the adjacent lattice fringes of nanocrystals imbeded is ∼0.193 nm, which is 
well consistent with the interplanar spacing of (220) of cubic CaF2 phase [20]. The 
XRD pattern of UCNPs confirms the presence of cubic CaF2 phase (JCPDS No. 35-0816) 
due to the presence of well-defined diffraction peaks at (111), (220) and (311), as 
well as the amorphous silicon dioxide phase (Fig 1d) [21]. No additional impurities 
were observed. The findings suggest CaF2 nanocrystals were successfully 
incorporated within MSNs matrix. When UCNPs were excited under 980 NIR laser, 
three narrow-band emission peaks at ～478 nm,～650 nm and ～800 nm presented 
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(Fig 1e), and the particles showed a blue color. The emission spectra observed 
correspond to the electron transitions of Tm3+ ions: 1G4→
3H6 (~478 nm), 
3F2→
3H6 
(~650 nm) and 3H4→
3H6 (～800 nm) [22]. Further, with the increased particle 
concentration from 0 to 200 µg mL
−1
, the relative cell viability with respect to the 
blank control retained over 90% viability after incubation for 24 and 48 h (Fig. 1f), 
reflecting low cell cytotoxicity of the particles synthesized. 
 
3.2 In vitro protein loading and releasing behavior 
The UCNPs prepared was subsequently surface-modified with amino groups to 
favor the protein loading procedure [23]. After surface modification, the appearance 
of the bonds at 2927 cm
−1
, 2870 cm
−1
 and 1560 cm
−1
 confirms the successful 
attachment of amino groups in organosilane at the surface of UCNPs (Fig. 2a). In 
consequence, the zeta potential of UCNPs varied from -15.6 mV to 30.3 mV owing to 
positive surface modification with amino groups (Fig. 2b). The nitrogen 
adsorption-desorption isotherm and corresponding textural parameters of UCNPs 
and amino-modified UCNPs are provided in Fig. 3 and Table 1, respectively. After 
amino modification, the surface area was reduced from 563.3 m
2
/g to 234.6 m
2
/g, 
and pore volume is decreased from 0.68 cm
3
/g to 0.42 cm
3
/g accordingly, that agrees 
well with previous studied [24]. The weakened nitrogen adsorption is induced by the 
blockage of pores on UCNPs by amino groups attached. The CCK-8 assay using 
fibroblast confirmed that amino-modified UCNPs, with varied concentrations from 10 
μg/mL up to 200 μg/mL, present at a high relative cell viability, reflecting its low cell 
cytotoxicity and good cytocompatibility (Fig. S4). In addition, amino-modified UCNPs 
with varied concentrations were dispersed in phosphate buffer saline (PBS) and 
simulate body fluid (SBF) solutions under irradiation using a laser point. Distinct 
‘Tyndall’ phenomena confirm the excellent colloidal stability of amino-modified 
UCNPs (Fig. S5). Under 980 nm NIR laser excitation, the surface modification did not 
induced wavelength shift of photoluminescent emission peaks (Fig. S6), but the 
relatively intensity of blue emission at ~478 nm decreased owing to the presence of 
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quenching groups in APTES molecules [25]. 
The FTIR spectra of UCNPs and amino-modified UCNPs after BSA loading are 
depicted in Fig. 4a. The infrared spectrum of BSA molecules consists of two amide 
peak regions, which are region I (2900–3000 cm
−1
) and II (1500–1700 cm
−1
). When 
particles were immersed in BSA solution for 24 h, absorption bands assigned to 
amide at ∼1540 cm
−1
, ∼1650 cm
−1
 and CHx bond at ∼2960 cm
−1
 were observed, 
confirming successful protein loading for both particles. TG curves in Fig. 4b show 
that, before BSA loading procedure, a marginal weight loss for UCNPs was induced 
due to the removal of adsorbed water, whereas the removed component for the 
amino-modified UCNPs system includes grafted APTES molecules as well as adsorbed 
water, resulting in increased weight loss. In contrast, after BSA protein loading, the 
weight loss of UCNPs (without surface modification) is ∼5.3%, indicating its loading 
capacity. For amino-modified UCNPs, however, although the BET surface area and 
pore volume are reduced due to amino-functionalization, the BSA protein loading 
capacity is increased remarkably to ~10.5 %. In general, BSA is negative charged at 
pH 7.4, and the zeta potential of UCNPs varied from -15.6 mV to 30.3 mV after amino 
modification. Negative charged BSA protein molecules interact favorably with 
positive charged UCNPs after amino-modification via electrostatic bonding [26]. 
Furthermore, the amino groups at the surface may also interact with BSA molecules 
by a hydrophilic absorption. Both mechanisms induce its high loading capacity [27]. 
Therefore, the amino-functionalized UCNPs exhibit significantly enhanced protein 
loading capacity. 
High loading capacity and sustained release behavior are expected but 
challenging aspects for intracellular protein delivery. UCNPs and amino-modified 
UCNPs after BSA protein loading were immersed in phosphate buffered saline (PBS, 
pH = 7.4) to enable the spontaneous protein release. As shown in Fig. 4c, both 
systems exhibit highly varied releasing phenomena. Within the initial 5 h, ∼50 % of 
BSA contents is released from UCNPs, and in contrast only ∼20% of total BSA 
molecules is liberated from amino-modified UCNPs. After 50 h, major BSA molecules 
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have been released from unmodified UCNPs. In contrast, the total amount of BSA 
released is only ∼35% for amino-modified UCNPs. UCNPs after amino-modification 
do not only present enhanced protein loading capacity but also induce significantly 
sustained release kinetics. For unmodified UCNPs, protein molecules, usually with 
large dimension, can hardly diffuse into the mesopores of MSNs and instead attach at 
the surface [26]. Meanwhile, UCNPs present a negative surface charge due to 
hydroxyl groups of MSNs matrix at the surface, and BSA molecule presents a 
negative net charge at pH 7.4. Thus, both UCNPs and BSA molecules were negatively 
charged in the neutral environment. The interaction between them belongs to 
physical adsorption [28, 29]. In this case, a ‘burst’ release phenomenon is more likely 
to occur [30]. However, for the amino-modified system, the more sustained releasing 
is induced by the ionic interaction between negative charged BSA molecules and the 
positive charged NH2 groups at the surface of UCNPs, which enhances the stability of 
the immobilized protein and markedly reduces the amount of leaching. Therefore, 
the release process of BSA molecules from the nanocarriers was dramatically 
postponed. In addition, the decreased surface area and pore volume may also 
facilitate the enduring BSA releasing. Such enhanced protein storage and sustained 
releasing properties of nanocarrier are beneficial for reducing the repeated 
administration and the delivery efficiency of macromolecular proteins to the cell. 
 
3.3 Optical-monitored BSA protein release process 
Monitoring of protein releasing progress in a real time manner is one iconic 
feature for modern multifunctional delivery systems. Owing to the intrinsic 
up-conversion (UC) photoluminescent characteristics of UCNPs designed, the 
relationship between the UC emission intensity of both BSA loaded UCNPs and 
protein release progress was uncovered. As shown in Fig. 5 (a-c), accompanying with 
BSA releasing, the intensity of blue emission (~478 nm) increases with the 
cumulative releasing progress, while the red emission intensity remained barely 
changed. The reason might be that the BSA molecules can be adsorbed onto the 
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surface of porous silica nanoparticles and quench some luminescent centers [31]. In 
general, the emission of rare earth ions is quenched by the environment with high 
phonon frequency [32]. The organic groups in BSA with high vibration frequencies 
from 1000 to 3500 cm
−1
 quench the emission of Tm
3+
 by a certain degree. It was also 
reported that the presence of organic ligands and OH groups may result in the 
quenching of green emission in NaYF4 nanoparticles codoped with Yb
3+
 and Er
3+
 [33]. 
In this work, BSA molecules attached at the surface of UCNPs may selectively quench 
the blue emission. In consequence, for UCNPs samples, the blue emission recovers in 
a relatively rapid fashion due to its fast protein release kinetics, and meanwhile a 
delayed blue emission recoverage was observed when using amino-modified UCNPs 
for BSA delivery. The variation of photoluminescent phenomenon has thus been 
confirmed to effectively reflect the protein releasing progress. 
The images of cells via the emission of amino-modified UCNPs were 
investigated using a modified confocal laser scanning microscopy (CLSM) equipped 
with infrared laser excitation at 980 nm. Hep G2 cells were incubated with 
amino-modified UCNPs (100 μg/mL) at 37 oC for 24 h prior to imaging procedure. As 
shown in Fig. 6, bright-field measurements after the treatment with amino-modified 
UCNPs confirm that the cells are viable throughout the imaging experiments. 
Moreover, an intense UC blue luminescence signal was observed from the Hep G2 
cell under laser excitation at 980 nm. Overlays of bright-field and UC luminescent 
images demonstrate that the luminescence presents in the intracellular region. In 
contrast, the control group presents no UC luminescence signal under excitation 
using 980 nm laser. To shed light on protein release monitoring within living cells, 
Hep G2 cells were incubated with BSA protein loaded amino-modified UCNPs (100 
μg/mL) at 37 
o
C for different period. A set of CLSM images were recorded to visualize 
the evolution of UC luminescence during intracellular protein release for 1, 3, 24, or 
48 h. As shown in Fig. 7, a clear enhancement of blue emission signal was observed 
as increasing incubation time. Generally, cellular uptaking behavior of silica 
nanoparticles (NPs) is a time-dependent increase manner [34]. Previous studies have 
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demonstrated that the cell-uptaking process of silica NPs occurs in the initial 10 h [34, 
35]. The sustained release profile of amino-modified UCNPs in cell-free solution 
indicates that as low as ~19% of BSA released within 3 h, and only ~30% of total protein 
loaded released within 24 h (Figure 4c). The major content of protein remained within 
the nanoparticles prior to the up-taking process by cells, and thus the luminescent 
intensity of the amino-modified UCNPs remained quenched by the protein loaded. The 
PL-quenched UCNPs uptaken by cells can not present the blue emission with a high 
magnitude under 980 nm excitation. Therefore, the increased amount of UCNPs within 
cells may not induce such clear increase of blue light signal. The dramatic increase of 
blue light during cell culture is therefore mainly attributed to the releasing of the 
protein loaded. Therefore, the phenomenon observed reflects the effective 
monitoring of protein release within cells. 
 
3.4 In vitro cellular up-taking of BSA protein 
Efficient cellular up-taking plays a fundamental role in protein delivery 
applications [36]. The intracellular delivery efficiency of BSA protein was preliminarily 
evaluated using Hep G2 cancer cells. The cells were incubated with blank control, 
free FITC-BSA solution, FITC-BSA-loaded UCNPs, and FITC-BSA-loaded amino-modified 
UCNPs, respectively. As the fluorescence microscope images revealed in Fig. 8a, the 
cellular up-taking efficiency for cells cultured with free FITC-BSA solution presented 
at a low magnitude after 24 h incubation as the naked protein molecules can hardly 
penetrate into cells [4]. When cultured with FITC-BSA loaded UCNPs and 
amino-modified UCNPs systems, the cellular up-taking effect was significantly 
enhanced compared to the blank control. Amino-modified UCNPs system presented 
remarkably enhanced fluorescent activity induced by FITC-BSA cellular up-taking than 
unmodified UCNPs. The increase of fluorescence intensity within the cells indicates 
that the FITC-BSA protein was successfully delivered into cancer cells. After 
prolonged incubation for 48 h, the fluorescent activity for both UCNPs and 
amino-modified UCNPs systems were further enhanced, while the cells cultured with 
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free FITC-BSA solution remained in dark due to the absence of any fluorescent 
activity within cells. The cells cultured with amino-modified UCNPs induced the 
strongest green fluorescence than other samples. The internalization of FITC-BSA 
molecules by the cells was analyzed quantitatively by flow cytometry (Fig. S7). As 
summarized in Fig. 8b, the protein up-taking efficiency by UCNPs and 
amino-modified UCNPs systems was determined to be ~27.9 % and ~49.4% after 24 h 
cell culture, respectively, and it reached ~56.8 % and ~73.6% after 48 h incubation. It 
is clear that amino-modified UCNPs system induced the remarkably enhanced cell 
up-taking efficiency owing to its high protein loading capacity. It is also noted that the 
prolonged incubation leads to increased cell up-taking efficiency for both systems. 
Such increasingly amplified protein up-taken efficiency induced by amino-modified 
UCNPs could be attributed to its high loading capacity and sustained intracellular 
release of protein molecules after particle internalization by cells. 
 
4. Conclusions 
Fine CaF2:Tm,Yb nanocrystals were incorporated within the mesopores of silica 
nanospheres. After surface modification with amino groups, the protein loading 
capacity was remarkably increased from 5.3 % to 10.5 %. Meanwhile, the 
amino-modified UCNPs present a more sustained release profile of BSA protein due 
to the electrostatic bonding formed between BSA molecules and amino groups. 
Additionally, the upconversion emission intensity of the nanoparticles corresponded 
well with the protein releasing progress. The preliminary in-vitro study using Hep G2 
cancer cells confirmed that amino-modified UCNPs induced significantly enhanced 
protein up-taking efficiency (up to ~73.6%) after 48 h. Owing to the excellent cellular 
uptaking performance and low toxicity, this new multifunctional protein delivery 
system may therefore offer a promising platform for intracellular delivery of various 
macromolecular proteins. 
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Figure captions 
Table 1. Texture properties of UCNPs before and after amino-modification. 
Scheme 1. Schematic illustration of CaF2:Tm,Yb@mSiO2 nanospheres designed for 
protein delivery. 
Figure 1. (a) SEM image (the inset shows nanosphere size distribution), (b) TEM 
images (the inset shows the corresponding SAED patterns), (c) HRTEM images, and 
(d) X-Ray diffraction patterns of crystalline CaF2:Tm,Yb@SiO2 nanospheres; (e) 
Photoluminescece spectrum under excited by 980 nm laser; (f) Relative cell viability 
of fibroblast incubated nanospheres with different concentrations for 24 h and 48 h. 
Figure 2. (a) FTIR spectra, and (b) Zeta potential of the UCNPs before and after 
amino- modification. 
Figure 3. (a) N2 adsorption/desorption isotherm; (b) mesopore pore size distribution 
of UCNPs and amino-modified UCNPs. 
Figure 4. (a) FTIR spectra of BSA molecules, BSA loaded UCNPs, BSA loaded 
amino-modified UCNPs (b) TG curves of UCNPs and amino-modified UCNPs before 
and after BSA protein loading, (c) Cumulative BSA protein release profiles of 
BSA-loaded UCNPs and amino-modified UCNPs in PBS (pH=7.4). 
Figure 5. (a, b) Spectra of upconversion emission as a function of release time for BSA 
loaded UCNPs and amino-modified UCNPs , (c) Upconversion emission of the 
intensity ratio of blue (
1
G4→
3
H6 (~478 nm) ) and red (
3
F2→
3
H6 (~650 nm)) (Iblue/Ired) as 
a function of release time. 
Figure 6 Confocal laser scanning microscopy (CLSM) images of Hep G2 cell incubated 
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with or without amino-modified UCNPs for 24 h under 980 nm excitation. The scale 
bar: 25 μm. 
Figure 7. Confocal laser scanning microscopy (CLSM) images of Hep G2 cell incubated 
with BSA loaded amino-modified UCNPs as a function of release time under 980 nm 
excitation. The scale bar: 25 μm. 
Figure 8. (a) Fluorescence microscopy images of Hep G2 cell cultured with FITC 
labelled BSA loaded amino-modified UCNPs and FITC labelled BSA loaded UCNPs, 
FITC labelled BSA and control. The scale bar is 100 μm, (b) Evaluation of cellular 
uptake of FITC labelled BSA protein by flow cytometry.
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Table 1. 
 
Samples Surface Area (m2/g) Volume (cm3/g) 
UCNPs 563.3 0.68 
Amino modified UCNPs 234.6 0.42 
 
Scheme 1 
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Fig. 6 
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Fig. 8 
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Graphical Abstract 
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Highlights 
 
 In situ growth of photoluminescent nanocrystals within mesopores of MSNs; 
 High protein loading and sustained release due to amino surface modification; 
 Cell up-taking rate of protein reaches ~75%; 
 Monitoring of protein release by the evolution of photoluminescence. 
 
 
